MILLWAY MEDICAL PRACTICE
2 HARTLEY AVENUE, MILL HILL, LONDON
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 20 | 29 | 69.0% | |
| HF 4 | 2011 | 16 | 22 | 72.7% | |
| HF 4 | 2012 | 17 | 24 | 70.8% | |
| HF 4 | 2013 | 19 | 25 | 76.0% | |
| HF004 | 2014 | 9 | 11 | 81.8% | |
| HF004 | 2015 | 10 | 13 | 76.9% | |
| HF004 | 2016 | 14 | 17 | 82.4% | |
| HF004 | 2017 | 14 | 21 | 66.7% | |
| HF004 | 2018 | 13 | 17 | 76.5% | |
| HF004 | 2019 | 17 | 21 | 81.0% | |
| HF004 | 2020 | 29 | 35 | 82.9% | |
| HF006 | 2021 | 32 | 39 | 82.1% | |
| HF006 | 2022 | 32 | 33 | 97.0% | |
| HF006 | 2023 | 36 | 36 | 100.0% |
